NCT07583433

Brief Summary

Laparoscopic surgery has revolutionized surgical care by reducing morbidity and improving post operative recovery. Laparoscopic surgery involves the use of carbon dioxide for insufflation to achieve optimal visualization. There is literature that demonstrates higher insufflation pressures being associated with increased postoperative pain - particularly shoulder pain - and opioid use. The ideal amount of intraperitoneal pressure is still under debate as other studies demonstrate that reduced pneumoperitoneum insufflation has also shown to negatively impact surgeon satisfaction and trended with longer operative time and greater blood loss without impacting pain. Residual intraperitoneal carbon dioxide can also contribute to postoperative discomfort. Studies have shown the effectiveness of various maneuvers in removing residual gas to reduce postoperative pain, such as intraperitoneal saline instillation, pulmonary recruitment, and gas aspiration via smoke evacuator. Despite these advantages, there is a lack of a clear consensus on the optimal method for reducing residual intraperitoneal gas. Conversely, literature has mixed results regarding the true significance in pain reduction. Given the importance of minimizing postoperative pain, reducing opioid requirements, and shortening postoperative recovery time, the investigators propose a prospective, patient-blinded, randomized controlled trial. The investigators aim to investigate whether active gas removal via a smoke evacuator, multiple breath recruitment maneuvers, or no intervention would contribute to lowest postoperative pain. The findings will help identify the most effective method for reducing residual pneumoperitoneum-related pain and thus inform surgical practices and improve patient outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
27mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Nov 2028

First Submitted

Initial submission to the registry

May 6, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

2.1 years

First QC Date

May 6, 2026

Last Update Submit

June 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post operative pain

    Post-operative pain: Patients will be assessed using the Numeric Rating Scale (NRS) by rating their pain on a scale from 0 (no pain) to 10 (worst pain imaginable) immediately prior to leaving the post-anesthesia care unit, on post-operative day 2, and post-operative day 7.

    From enrollment until 1 week post surgery

Secondary Outcomes (1)

  • Opioid use for the management of post operative pain

    Time of enrollment until their post operative appointment up to 2 weeks from the time of surgery

Study Arms (3)

Smoke Evacuation Group

EXPERIMENTAL
Procedure: Smoke Evacuation Group

Recruitment Breath Group

EXPERIMENTAL
Procedure: Recruitment Breath Group

Control Group

PLACEBO COMPARATOR
Procedure: Control Group

Interventions

Active gas removal via smoke evacuator for 30 seconds at the end of case.

Smoke Evacuation Group

Repeated pulmonary inflation maneuvers: Three (3) consecutive manual ventilations at maximum of 30 cm water at the end of case.

Recruitment Breath Group
Control GroupPROCEDURE

Passive desolation of the pneumoperitoneum at the end of the laparoscopic surgery.

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients age 18 to 65
  • Benign, elective laparoscopic surgeries

You may not qualify if:

  • Ages \<18 and age \>65
  • Emergency or urgent surgeries
  • Surgeries for chronic pelvic pain, malignancy
  • Surgeries during pregnancy
  • Severe cardiopulmonary disease
  • Prior extensive abdominal surgeries (more than 2 abdominal or pelvic surgeries)
  • Inability to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Pain, PostoperativePneumoperitoneum

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPeritoneal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 13, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

November 1, 2028

Last Updated

June 9, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations